Journal of Clinical Investigation The discovery that multiciliated cells in the nasal epithelium are the first cells to be targeted in early COVID-19 infection might provide the rationale… read more.
A University of Arkansas researcher and international colleagues found that employed individuals, on average, are 35.3% more likely to be infected with the flu virus. The findings confirm… read more.
Interview and article by Christine Clark. Some four million extra prescriptions for antidepressants were issued in 2020 compared to 2019 but the cost to the NHS increased by… read more.
On 25 June 2021 the Therapeutic Goods Administration (TGA) granted provisional approval to Janssen-Cilag Pty Ltd (known as Johnson & Johnson overseas) for its COVID-19 vaccine Janssen, making… read more.
Gilead Sciences, Inc. announced positive data from three retrospective studies of the real-world treatment of patients hospitalized with COVID-19, adding to the body of mortality and hospital discharge… read more.
Article written by Christine Clark. The long-awaited systematic review of ivermectin trials from Dr Tess Lawrie’s team at the Evidence-based Medicine Consultancy has now been published in the… read more.
Interview and article by Christine Clark. The anti-tumour effects of ivermectin have been described in the literature and the liposomal delivery system developed by Mountain Valley MD could… read more.
Interview and article by Christine Clark. Liposomal drug delivery holds out the prospect of oral drug administration without the need for water and more economical use of oral… read more.
Interview and article by Christine Clark. Patented solubilisation technology improves the bioavailability of oral ivermectin and makes possible the formulation of an ivermectin injection for human use, according… read more.
Reduced levels of a metabolic hormone known as leptin is linked to poor vaccine antibody responses in the general population, a University of Queensland study has found. The… read more.
Interview and article by Christine Clark. Steve Kirsch, CEO of the Covid-19 Early Treatment Fund (CETF) explains how a study in Nepal will advance our understanding of effective… read more.
Interview and article by Christine Clark. A combination of fluvoxamine and ivermectin for early treatment of covid-19 is highly effective and should be implemented widely, according to Steve… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
